Abstract
Methods: Over a three year period, the study recruited 82 patients of dental clinics in Moscow, who had gastrointestinal and/or respiratory diseases. They were both men and women aged 41 to 70 years average age of 60.1+ 0.9years. Patients were divided into groups: gastrointestinal disorders (Group 1 - 20 smokers, Group 2 - 22 non-smokers) and with respiratory diseases (Group 3 - 20 smokers, Group 4 - 20 non- smokers). The study was conducted with the permission of the Inter- University Ethical Committee of Moscow. The following oral assessments were made: OHI-S, DMFT, gingival bleeding: sialometry to assess the buffering capacity of saliva, microbiology assay of scrapings from the tongue. Results: As far as xerostomia was concerned in Group 1 this was found in 11 (55%), in Group 2 in 10 (45.5%), in Group 3 in 17 (89.5%) and in Group 4 in 15 (71.4%) of patients. Gingival bleeding was found as follows: in Group 1 in 18 (90%), in Group 2 in 16 (72.7%), in Group 3 in 19 (95%) and in Group 4 in 16 (80%). The mean (DMFT) was 22.7±0.8 in Group 1, 25.0±0.9 in Group 2, 21.0±0.5 in Group 3 and 20.4±0.5 in Group 4. The results for several other clinical findings, including salivation rates and microbiological assays are reported in the poster.
Conclusion: In the groups studied smokers appeared to have higher levels of oral disease. Further investigation with larger groups and statistical testing is required to confirm these findings. Smoking is one of the most important public health problems worldwide. It causes or is a contributory factor for many diseases including gastrointestinal and respiratory diseases.
Aim: This study aimed to compare the oral health status of smokers with gastrointestinal or respiratory disease with non-smokers who also had these diseases.
Get full access to this article
View all access options for this article.